Health Care & Life Sciences » Pharmaceuticals | Hyundai Pharmaceutical Co. Ltd.

Hyundai Pharmaceutical Co. Ltd. | Mutual Funds

Mutual Funds that own Hyundai Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
DFA Emerging Markets Small Cap Series
191,697
0.6%
22,901
0.01%
01/31/2018
DFA Emerging Markets Core Equity Portfolio
177,774
0.56%
0
0%
04/30/2018
Dimensional Funds ICVC - Emerging Markets Core Equity Fund
9,247
0.03%
888
0%
12/31/2017
8,023
0.03%
5,357
0.02%
04/30/2018
John Hancock II - Emerging Markets Fund
6,292
0.02%
0
0%
04/30/2018
DFA TA World (ex-US) Core Equity Portfolio
5,505
0.02%
0
0%
04/30/2018
3,694
0.01%
3,694
0.2%
07/06/2018

About Hyundai Pharmaceutical Co.

View Profile
Address
55 Jandari-gil
Cheonan SC 31213
Korea, Republic Of
Employees -
Website http://www.hyundaipharm.co.kr
Updated 07/08/2019
Hyundai Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products, health food drinks and medical equipment. Its major products include ethical drugs (ETC) and over-the-counter (OTC) drugs. The company was founded on July 16, 1965 and is headquartered in Cheonan, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.